Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
NIMGenetics logo — Innovamos en medicina pensando en ti

NIMGenetics

Innovamos en medicina pensando en ti

Founded 2008 Spain Spain 89 employees Venture round Total: $7.00M Biotechnology, Health Care

General Information

Company Name NIMGenetics
Founded Year 2008
Location Spain Spain
Founders / Decision Makers
Team member
Employees 89
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with NIMGenetics. To contact NIMGenetics, visit nimgenetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NIMGenetics compare?

A PDF of NIMGenetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NIMGenetics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NIMGenetics

NIMGenetics is a Spanish biotechnology and healthcare company, founded in 2007, that operates as an analytical diagnostic center with a genetics unit authorized by the Health Department of the Community of Madrid. The company's accredited scientific and medical team is specialized in high-resolution genomic systems, aiming to provide reliable and precise clinical diagnosis. One of NIMGenetics' main objectives is to efficiently provide medical professionals with the latest scientific advances in genomic tools, such as CGH arrays, to enhance healthcare in terms of prevention, prognostic characterization, and diagnostic reliability. Additionally, the company offers personalized services to researchers and research institutions, including the design and selection of suitable platforms and comprehensive bioinformatic analysis. Since 2008, NIMGenetics has been backed by the CDTI, enhancing its innovation capabilities. The company has developed and validated various genomic analysis platforms with clinical applicability, such as KaryoNIM®, which facilitates the identification of DNA copy number alterations with phenotypic repercussions. In 2009, NIMGenetics was accredited by the Health Department of the Community of Madrid as an Analytical Diagnostic Center with a Genetics Unit. Currently, over 50 diagnostic centers, clinics, and hospitals utilize NIMGenetics' services. In May 2017, the company received a significant €7.00M Venture Round investment led by Apposite Capital. This investment has further bolstered NIMGenetics' position in the biotechnology and healthcare space, potentially paving the way for continued growth and innovation in the company's offerings.

Business keywords: genetics, diagnostic analysis, medical innovation, genomic tools, bioinformatics, clinical diagnosis, CDTI, karyotyping, genomic platforms, healthcare advancement, phenotypic impact, research services, genetic testing, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €7.00M 1
Apposite Capital
Apposite Capital
10 May 2017

NIMGenetics Alternatives & Competitors

View All Alternatives
NIMGenetics vs
Mendelics
Mendelics Brazil

Análise genômica ao alcance de todos

154 employees
Biotechnology, Health Care
Compare NIMGenetics vs Mendelics
NIMGenetics vs
广州嘉检医学检测有限公司
广州嘉检医学检测有限公司 China

使命宣言： •为我们的民众提供高品质的，临床合理的综合诊断和咨询服务，通过个性化诊断实现精准医学。...

Series B
27 employees
Biotechnology, Care Economy
Compare NIMGenetics vs 广州嘉检医学检测有限公司
NIMGenetics vs
NalaGenetics
NalaGenetics Singapore

Unlock your health secrets through the power of DNA

Non Equity Assistance
73 employees
Biotechnology, Health Care
View all alternatives

FAQ About NIMGenetics

Innovamos en medicina pensando en ti
NIMGenetics was founded in 2008.
NIMGenetics is headquartered in Spain.
NIMGenetics operates in Biotechnology and Health Care. Its work centres on genetics, diagnostic analysis, medical innovation and genomic tools.
NIMGenetics has approximately 89 employees.
NIMGenetics has completed 1 funding round, raising a total of $7.00M. The latest funding stage is Venture round.
Top alternatives and competitors to NIMGenetics include Mendelics, 广州嘉检医学检测有限公司, NalaGenetics, Genomics, Perlegen Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NIMGenetics and Mendelics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NIMGenetics, https://bouncewatch.com/company/nimgenetics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout